Rawson ES, Volek JS
A., Fauth, C., Bergheim, C., Meierhofer, D., Radmayr, D., Zschocke, J., Koch, J., and Sperl, W
Decision framework Your prescriber can help check insurance coverage, which often determines the real-world choice
Research community forums and discussion groups often identify problematic vendors and highlight reliable sources
One human trial found 3 g/m2 intravenous glutathione given 20 minutes prior to cisplatin (100 mg/m2) led to a significant reduction in nephrotoxicity in patients with ovarian cancer compared with those receiving cisplatin alone
Tharakan, A., Shukla, H., Benny, I